International Perspectives on the Challenges and Opportunities in Psychedelic Science Research
This symposium, hosted by the Psychedelic and Enthegeon Academic Council (PEAC) at UCSF, and the Multidisciplinary Association for Psychedelic Studies (MAPS), will be focused on advancing the discussions around doing clinical trials in the United States to assess the safety and efficacy of ayahuasca in healthy participants and PTSD patients.
The meeting aims to leverage the expertise of Brazilian researchers who have successfully conducted clinical trials on ayahuasca, and other related topics in the field of psychedelic science. Some of the questions addressed include:
- What methodological and epistemological challenges arise when conducting clinical research into psychedelic substances?
- How are participants and researchers benefiting from the interventions, and how might trials be designed to best document this?
- How is the placebo effect framed and shaped by clinical trial methodologies, and how could it be framed differently?
- What kind of a ‘problem’ is placebo?
- What role do the psychedelics themselves play in the learning processes of participants and researchers, and how should we understand the roles that other factors play?
- Can the knowledge we are gaining about psychedelics be translated across different substances, sets, settings and disciplinary registers?
Tuesday, April 25, 2017 at 7:00pm
Toland Hall Auditorium, U-142
533 Parnassus Avenue, San Francisco, California 94143